Effective control of persistent asthma often involves daily use of inhaled corticosteroids, which calm inflammation and prevent exacerbations. Beclate Rotacaps deliver beclomethasone dipropionate in a dry powder form suitable for administration via a Rotahaler device. Designed for maintenance therapy, these rotacaps help reduce airway swelling, ease breathing and lower the frequency of asthma attacks when used consistently.
Each rotacap contains a measured amount of beclomethasone that is released directly into the lungs upon inhalation. This targeted delivery ensures the medication acts locally with minimal systemic absorption, reducing the risk of widespread side effects. Beclate Rotacaps are usually prescribed for adults and children who require regular anti-inflammatory treatment. They are not intended for quick relief of acute asthma symptoms; rather, they form part of a long-term management plan.
To use Beclate Rotacaps, insert a capsule into the Rotahaler, twist to pierce the capsule, and then inhale deeply through the mouthpiece. Hold your breath for a few seconds to allow the powder to reach the airways, and then exhale slowly. Rinse your mouth and spit out the water after each dose to reduce the risk of oral thrush or hoarseness. Common side effects include a hoarse voice, throat irritation or occasional cough. Rarely, prolonged high-dose therapy may lead to systemic steroid effects such as adrenal suppression or decreased bone mineral density.
Consistency is key to gaining the full benefit of inhaled corticosteroids. Do not discontinue Beclate Rotacaps abruptly without consulting your healthcare provider. Your doctor may adjust your dosage based on symptom control and peak flow measurements. Keep the rotacaps sealed in their original blister packs until use, store them in a dry place away from moisture and heat, and ensure that children cannot access them. When paired with regular monitoring and a comprehensive asthma action plan, Beclate Rotacaps can contribute significantly to long-term asthma control.
Each rotacap contains a measured amount of beclomethasone that is released directly into the lungs upon inhalation. This targeted delivery ensures the medication acts locally with minimal systemic absorption, reducing the risk of widespread side effects. Beclate Rotacaps are usually prescribed for adults and children who require regular anti-inflammatory treatment. They are not intended for quick relief of acute asthma symptoms; rather, they form part of a long-term management plan.
To use Beclate Rotacaps, insert a capsule into the Rotahaler, twist to pierce the capsule, and then inhale deeply through the mouthpiece. Hold your breath for a few seconds to allow the powder to reach the airways, and then exhale slowly. Rinse your mouth and spit out the water after each dose to reduce the risk of oral thrush or hoarseness. Common side effects include a hoarse voice, throat irritation or occasional cough. Rarely, prolonged high-dose therapy may lead to systemic steroid effects such as adrenal suppression or decreased bone mineral density.
Consistency is key to gaining the full benefit of inhaled corticosteroids. Do not discontinue Beclate Rotacaps abruptly without consulting your healthcare provider. Your doctor may adjust your dosage based on symptom control and peak flow measurements. Keep the rotacaps sealed in their original blister packs until use, store them in a dry place away from moisture and heat, and ensure that children cannot access them. When paired with regular monitoring and a comprehensive asthma action plan, Beclate Rotacaps can contribute significantly to long-term asthma control.
0